Argenx Se (ARGX) Long-Term Investments (2015 - 2025)

Argenx Se (ARGX) posted quarterly Long-Term Investments of $3.4 million for Q4 2025, down 63.55% year-on-year from $9.3 million in Q4 2024, and down 99.97% on a QoQ basis from $10.7 billion in Q2 2025.

Argenx Se (ARGX) Long-Term Investments (2015 - 2025) Analysis & Trends

Argenx Se (ARGX) has reported Long-Term Investments for 11 consecutive years, with $3.4 million the latest figure, recorded in Q4 2025.

  • Quarterly Long-Term Investments fell 63.55% year-over-year to $3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (down 63.55% YoY) and the FY2025 annual result came in at -$6.5 million, down 170.13% from the prior year.
  • Long-Term Investments eased to $3.4 million in Q4 2025 per ARGX's latest filing, from $10.7 billion in the prior quarter.
  • Over the last five years, Long-Term Investments for ARGX reached as high as $10.7 billion in Q2 2025 and fell as low as -$370.3 million in Q2 2021.
  • A 5-year average of $1.0 billion and a median of $7.9 million in 2024 frame the typical range for Long-Term Investments.
  • Annual changes were most pronounced in 2021 — Long-Term Investments sank 223.7% — and 2025, when it surged 161757.86%.
  • Year by year, Long-Term Investments stood at $76.7 million in 2021, then tumbled by 98.27% to $1.3 million in 2022, then jumped by 649.21% to $9.9 million in 2023, then fell by 6.5% to $9.3 million in 2024, then plunged by 63.55% to $3.4 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $3.4 million, $10.7 billion, and $9.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 505,194.89
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.79 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 22.17 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.38 Mn
Jun 30, 2025 10.68 Bn
Dec 31, 2024 9.27 Mn
Jun 30, 2024 6.60 Mn
Dec 31, 2023 9.91 Mn
Jun 30, 2023 12.44 Mn
Dec 31, 2022 1.32 Mn
Jun 30, 2022 -234.24 Mn
Dec 31, 2021 76.66 Mn
Jun 30, 2021 -370.34 Mn
Dec 31, 2020 5.85 Mn
Jun 30, 2020 299.38 Mn
Dec 31, 2019 2.95 Mn
Jun 30, 2019 -555.93 Mn
Mar 31, 2019 23.90 Mn
Dec 31, 2018 1,137.95
Jun 30, 2018 -41.96 Mn
Dec 31, 2017 1,443.21
Jun 30, 2017 -131.43 Mn
Dec 31, 2016 1,443.21